SS-31
Typical Dosage
2-5 mg
Administration
Injection
Half-Life
~4 hours
Mechanism of Action
Mitochondrial membrane stabilization|Ischemia/reperfusion studies|Muscle fatigue research|Age-related organ dysfunction
Research Protocol Summary
Evidence Level
Early Human / Investigational
Typical Protocol Duration
12 Weeks
Species Studied
Human • Mouse • Rat
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…